For the quarter ending 2025-09-30, GERN had $389K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -18,428 | -36,210 |
| Depreciation and amortization | 128 | 259 |
| Accretion and amortization on investments, net | 1,529 | 3,948 |
| Amortization of debt issuance costs/debt discounts | 273 | 515 |
| Non-cash interest expense on liabilities for sales of future royalties | 5,163 | 9,880 |
| Stock-based compensation for services by non-employees | 29 | 41 |
| Stock-based compensation for employees and directors | 6,742 | 14,146 |
| Amortization of right-of-use assets | 184 | 358 |
| Increase in allowance for doubtful accounts | -25 | 21 |
| Inventory | 26,298 | 30,410 |
| Accounts receivable, net | -1,273 | 684 |
| Prepaid expenses, interest receivable and other assets | -1,340 | 1,173 |
| Current and noncurrent liabilities | 21,370 | -21,484 |
| Payment on royalty agreement | 3,798 | 6,705 |
| Net cash used in operating activities | -13,576 | -75,394 |
| Purchases of property and equipment | -89 | 138 |
| Purchases of marketable securities | 77,029 | 123,173 |
| Proceeds from maturities of marketable securities | 90,288 | 196,065 |
| Net cash provided by (used in) investing activities | 13,348 | 72,754 |
| Proceeds from issuances of common stock from equity plans | 542 | 847 |
| Proceeds from issuance of common stock from offering and pre-funded warrant, net of paid issuance costs | 0 | 0 |
| Proceeds from exercise of warrants | 0 | 0 |
| Proceeds from employee stock purchase plan | 0 | 500 |
| Net cash provided by financing activities | 542 | 1,347 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 75 | 21 |
| Net increase in cash, cash equivalents and restricted cash | 389 | -1,272 |
| Cash and cash equivalents at beginning of period | 80,876 | - |
| Cash and cash equivalents at end of period | 79,993 | - |
GERON CORP (GERN)
GERON CORP (GERN)